MEDTRONIC TRANSFORM CARDIOMYOSTIMULATOR DEVICE PHASE IV TRIAL UNDERWAY
This article was originally published in The Gray Sheet
Executive Summary
MEDTRONIC TRANSFORM CARDIOMYOSTIMULATOR DEVICE PHASE IV TRIAL UNDERWAY at 20 U.S. and foreign medical centers. The company gained FDA approval of a supplemental investigational device exemption in August for the 600-patient, randomized study of the Model SP 1005 Transform.